GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CombiGene AB (OSTO:COMBI) » Definitions » Other Long Term Assets

CombiGene AB (OSTO:COMBI) Other Long Term Assets : kr0.09 Mil (As of Sep. 2024)


View and export this data going back to 2015. Start your Free Trial

What is CombiGene AB Other Long Term Assets?

CombiGene AB's other long-term assets for the quarter that ended in Sep. 2024 was kr0.09 Mil.

CombiGene AB's quarterly other long-term assets increased from Mar. 2024 (kr0.00 Mil) to Jun. 2024 (kr0.00 Mil) and increased from Jun. 2024 (kr0.00 Mil) to Sep. 2024 (kr0.09 Mil).

CombiGene AB's annual other long-term assets stayed the same from Dec. 2021 (kr-0.00 Mil) to Dec. 2022 (kr-0.00 Mil) but then increased from Dec. 2022 (kr-0.00 Mil) to Dec. 2023 (kr0.00 Mil).

CombiGene AB Other Long Term Assets Historical Data

The historical data trend for CombiGene AB's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CombiGene AB Other Long Term Assets Chart

CombiGene AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Long Term Assets
Get a 7-Day Free Trial - - - - -

CombiGene AB Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Other Long Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - 0.09

CombiGene AB Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

CombiGene AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CombiGene AB (OSTO:COMBI) » Definitions » Other Long Term Assets
Comparable Companies
OSTO:ONCOZ XSAT:DBP B OSTO:SIMRIS B OSTO:EXPRS2 XSAT:CHOSA OSTO:CMOTEC B OSTO:NANECH XSAT:RESP OSTO:ELIC XSAT:PHAL VRTX ASX:CSL REGN XKRX:207940 XBRU:UCB XBRU:ARGX ALNY BNTX XKRX:068270 BGNE
Traded in Other Exchanges
N/A
Address
Agavagen 52A, Lidingo, SWE, SE-181 55
Website
https://www.combigene.com
CombiGene AB is a gene therapy explorer based in Sweden. The company is engaged in developing new methods for the treatment of neurological diseases and for epileptic patients who cannot be helped by available medical treatments at present. It develops gene therapies with the ambition to offer patients affected by severe life-changing diseases opportunities for a better life.

CombiGene AB Headlines

No Headlines